基因扩增技术的全球市场规模、份额和成长分析：按技术和最终用户划分 - 产业预测（2024-2031）

2022年全球基因扩增技术市场规模将为39.6亿美元，从2023年的43.6亿美元扩大到2031年的93.4亿美元，并预计在预测期内（2024-2031年）持续增长。2018 年复合年成长率为10%）。

在分子生物学和诊断技术开拓的推动下，基因扩增技术的全球市场正经历强劲成长。扩大在个人化医疗、生物技术研究和疾病诊断的应用是重要的动机。该产业以等温扩增和聚合酵素链锁反应（PCR）扩增方法为主，但基于 CRISPR 的扩增方法正变得越来越普及。北美由于其强大的研发和医疗基础设施而占据了重要的市场占有率。由于医疗保健支出增加和技术使用增加，亚太地区正在经历快速成长。随着基因组学继续影响医学和研究领域，基因扩增技术市场预计将稳定成长。

目录

执行摘要

• 市场概况
• 转型

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管环境
• 波特的分析
• 对未来中断的特殊考虑

基因扩增技术的全球市场：依技术分类

• 市场概况
• PCR
• NASBA
• LAMP
• 其他的

基因扩增技术的全球市场：依最终用户划分

• 市场概况
• 学术/研究机构
• 诊断实验室
• 製药公司

基因扩增技术的全球市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• Thermo Fisher Scientific（USA）
• Roche Diagnostics（Switzerland）
• Agilent Technologies（USA）
• QIAGEN（Netherlands）
• Bio-Rad Laboratories（USA）
• Illumina（USA）
• Beckman Coulter（USA）
• Fluidigm Corporation（USA）
• Merck KGaA（Germany）
• BioMerieux（France）
• GenMark Diagnostics（USA）
• Cepheid（USA）
• Luminex Corporation（USA）
• Enzo Biochem（USA）
• Takara Bio（Japan）
• Sysmex Corporation（Japan）
• Promega Corporation（USA）
• Becton, Dickinson and Company（USA）
• DiaSorin SpA（Italy）
• Eppendorf（Germany）

Global Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, growing at a CAGR of 10% during the forecast period (2024-2031).

The development of molecular biology and diagnostics has led to a strong increase in the global market for gene amplification technologies. Personalized medicine, biotechnology research, and growing applications in disease diagnostics are important motivators. The industry is dominated by isothermal and polymerase chain reaction (PCR) amplification methods, however CRISPR-based amplification is becoming more and more popular. Due to its robust R&D and healthcare infrastructure, North America has a sizable market share. Asia-Pacific is growing quickly as a result of increased healthcare spending and technology usage. With genomics continuing to influence the medical and research fields, the market for gene amplification technologies is expected to grow steadily.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Amplification Technologies Market Segmental Analysis

One may divide the worldwide market for gene amplification technologies into three segments: technology, end-user, and geography. Some examples of technological segments are LAMP, NASBA, PCR, and others. Pharmaceutical firms, academic and research institutes, and diagnostic labs are examples of end-users. The market is split geographically into Latin America, North America, Europe, Asia Pacific, the Middle East, and Africa.

Drivers of the Global Gene Amplification Technologies Market

The global market for gene amplification technologies is expanding due to the growing need for customized treatment and biotechnology breakthroughs. These technologies allow for the accurate and efficient examination of genetic material for research and diagnostic reasons.

Restraints in the Global Gene Amplification Technologies Market

Market expansion is impeded by ethical concerns over genetic manipulation, intricate regulatory frameworks, and high costs linked to gene amplification technologies. These factors may limit the broad use and growth of these technologies in the worldwide market.

Market Trends of the Global Gene Amplification Technologies Market

Key developments in the global gene amplification technologies market include the quick development of CRISPR-Cas9 technology, which allows for accurate and effective gene editing. Market growth is being propelled by expanding applications in biotechnology, agriculture, and medical research. Furthermore, the need for gene amplification techniques is fueled by the growth of customized medicine and synthetic biology. Efficiency gains come from automation and high-throughput capacities. Nonetheless, there are still issues with genetic modification in terms of ethics and regulations. All things considered, the market is driven by innovation, a wide range of applications, and rising funding for genetic research, with an emphasis on both therapeutic and non-therapeutic uses.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Gene Amplification Technologies Market by Technology

• Market Overview
• PCR
• NASBA
• LAMP
• and others

Global Gene Amplification Technologies Market by End user

• Market Overview
• Academic & research institutions
• diagnostic labs
• and pharmaceutical companies

Global Gene Amplification Technologies Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments